Target Validation Information
TTD ID T53748
Target Name Plasmodium Enoyl-ACP reductase (Malaria fabI)
Type of Target
Successful
Drug Potency against Target Triclosan Drug Info IC50 = 100 nM [7]
(-)-CATECHINGALLATE Drug Info Ki = 40 nM [2]
2-(2,4-dichlorophenoxy)-5-(2-methylbutyl)phenol Drug Info IC50 = 290 nM [6]
2-(2,4-dichlorophenoxy)-5-(3-phenylpropyl)phenol Drug Info IC50 = 440 nM [4]
2-(2,4-dichlorophenoxy)-5-ethylphenol Drug Info IC50 = 110 nM [4]
2-(2,4-dichlorophenoxy)-5-isobutylphenol Drug Info IC50 = 180 nM [6]
2-(2,4-dichlorophenoxy)-5-isopentylphenol Drug Info IC50 = 120 nM [6]
2-(2,4-dichlorophenoxy)-5-methylphenol Drug Info IC50 = 200 nM [4]
2-(2,4-dichlorophenoxy)-5-phenethylphenol Drug Info IC50 = 76 nM [6]
2-(2,4-dichlorophenoxy)-5-propylphenol Drug Info IC50 = 210 nM [4]
2-(4-amino-2-chlorophenoxy)-5-chlorophenol Drug Info IC50 = 360 nM [1]
2-(4-chloro-2-hydroxyphenoxy)benzenaminium Drug Info IC50 = 7000 nM [6]
3,7,3',4'-TETRAHYDROXYFLAVONE Drug Info IC50 = 1000 nM [2]
3,7-dihydroxy-flavone Drug Info IC50 = 10000 nM [2]
3-chloro-4-(4-chloro-2-hydroxyphenoxy)benzamide Drug Info IC50 = 120 nM [1]
4-(2,4-dichloro-phenoxy)-2'-methyl-biphenyl-3-ol Drug Info IC50 = 440 nM [4]
4-(2,4-dichloro-phenoxy)-4'-fluoro-biphenyl-3-ol Drug Info IC50 = 38 nM [4]
4-(2,4-dichloro-phenoxy)-biphenyl-3-ol Drug Info IC50 = 140 nM [4]
4-(2,4-dichlorophenoxy)-3'-methylbiphenyl-3-ol Drug Info IC50 = 230 nM [6]
4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile Drug Info IC50 = 49 nM [4]
4-(2,4-dichlorophenoxy)-4'-methylbiphenyl-3-ol Drug Info IC50 = 190 nM [6]
5-benzyl-2-(2,4-dichlorophenoxy)phenol Drug Info IC50 = 71 nM [6]
5-butyl-2-(2,4-dichlorophenoxy)phenol Drug Info IC50 = 480 nM [6]
5-chloro-2-(2-chloro-4-hydroxyphenoxy)phenol Drug Info IC50 = 220 nM [1]
5-chloro-2-(2-chloro-4-nitrophenoxy)phenol Drug Info IC50 = 180 nM [1]
BUTEIN Drug Info Ki = 14 nM [3]
Epigallocatechin gallate Drug Info Ki = 8 nM [3]
GALLOCATECHIN GALLATE Drug Info IC50 = 500 nM [2]
ISORHAMNETIN Drug Info IC50 = 5000 nM [2]
MORIN Drug Info IC50 = 5000 nM [2]
OROIDIN Drug Info Ki = 800 nM [5]
References
REF 1 Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. ... Bioorg Med Chem Lett. 2005 Dec 1;15(23):5247-52.
REF 2 Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem. 2006 Jun 1;49(11):3345-53.
REF 3 Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J Med Chem. 2007 Feb 22;50(4):765-75.
REF 4 X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalar... J Biol Chem. 2007 Aug 31;282(35):25436-44.
REF 5 Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tubercul... Bioorg Med Chem. 2007 Nov 1;15(21):6834-45.
REF 6 Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier pr... Eur J Med Chem. 2009 Jul;44(7):3009-19.
REF 7 Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis. Curr Top Med Chem. 2007;7(5):489-98.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.